Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa

Completed · Phase 1/Phase 2

Conditions studied: Melanoma (Skin)

In brief

RATIONALE: Interferon alfa may interfere with the growth of tumor cells. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining interferon alfa plus radiation therapy may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of interferon alfa plus radiation therapy in treating patients who have stage III or recurrent melanoma that has been removed by surgery.

Key facts

Study ID

NCT00005615

Run by

H. Lee Moffitt Cancer Center and Research Institute

People needed

24

Starts

1997-07-01

Expected to finish

2005-12-01

Last updated by the study team

2012-09-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Sylvester Cancer Center, University of Miami — Miami, Florida, United States
• H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.